VistaPath Biosystems

About:

VistaPath Biosystems develops a tissue grossing platform that automates the process of inspecting, inking, and measuring tissues.

Website: https://www.vistapath.ai

Twitter/X: VistaPathBio

Top Investors: NextGen Venture Partners, Cota Capital, First Star Ventures, Moxxie Ventures, MIT Venture Mentoring Service (MIT VMS)

Description:

VistaPath Biosystems develops a tissue grossing platform that automates the process of inspecting, describing, inking, and measuring tissues that are to be processed for diagnosis. The company's platform automatically locates, measure and image tissue as it's placed into the cassette, eliminate mix-ups and errors, visualize specimens and easily see and react to changes in workload, enabling pathologists to prepare samples for diagnosis automatically and reduce errors involved with the process.

Total Funding Amount:

$8.91M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2017-01-01

Contact Email:

info(AT)vistapathbio.com

Founders:

Ben Burley, Timothy Spong

Number of Employees:

11-50

Last Funding Date:

2024-06-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai